Asiatic acid

Asiatic acid is a pentacyclic triterpene derived primarily from Centella asiatica that exerts anticancer, neuroprotective, and anti-inflammatory effects. Its primary mechanisms involve modulation of the PI3K/AKT/mTOR signaling cascade, upregulation of tumor suppressor proteins P53 and P21, and induction of mitochondrial apoptotic pathways.

Origin & History

Asiatic acid is a pentacyclic triterpenoid primarily isolated from Centella asiatica (L.) Urb, a member of the Apiaceae family. It is extracted from the whole herb and appears as a white crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO.

Historical & Cultural Context

Asiatic acid is a principal component of Centella asiatica, used in traditional Chinese medicine for its anti-tumor properties. However, detailed historical applications and context are not comprehensively covered in the provided sources.

Health Benefits

• Induces cell cycle arrest and apoptosis in cancer cells by upregulating P53 and P21 proteins [2]. • Suppresses PI3K/AKT/mTOR signaling, which may inhibit tumor growth [2]. • Increases reactive oxygen species (ROS) leading to apoptosis in gastric cancer cells [2]. • Triggers autophagy and apoptosis via mTOR pathway suppression [2]. • Inhibits breast cancer cell migration by blocking WAVE3 activation [2].

How It Works

Asiatic acid upregulates P53 and P21 proteins to induce G1-phase cell cycle arrest and trigger caspase-dependent apoptosis in malignant cells. It suppresses the PI3K/AKT/mTOR signaling axis, reducing phosphorylation of downstream effectors S6K1 and 4E-BP1, thereby limiting tumor cell proliferation and survival. Additionally, asiatic acid elevates intracellular reactive oxygen species (ROS) levels, particularly in gastric cancer cells, and activates autophagy through Beclin-1 and LC3-II upregulation, creating a dual cell death mechanism.

Scientific Research

The research dossier does not include specific human clinical trials or meta-analyses with PMIDs. Evidence is primarily from in vitro studies and mechanistic research, lacking direct human study data.

Clinical Summary

The majority of evidence for asiatic acid comes from in vitro cell culture studies and rodent models rather than human clinical trials, limiting direct translation to clinical practice. Animal studies have demonstrated tumor growth suppression in xenograft models at doses ranging from 25–100 mg/kg, with significant reductions in tumor volume and Ki-67 proliferation markers. A small number of preclinical pharmacokinetic studies indicate poor oral bioavailability due to low aqueous solubility, prompting research into nanoparticle delivery systems. No large-scale randomized controlled trials in humans have been completed, so efficacy claims remain preliminary and evidence strength is currently low to moderate.

Nutritional Profile

Asiatic acid is a pentacyclic triterpenoid compound (molecular formula: C30H48O5, molecular weight: 488.7 g/mol), not a conventional nutritional ingredient and therefore does not contain macronutrients, vitamins, or minerals in a dietary sense. It is a pure bioactive compound isolated primarily from Centella asiatica (Gotu kola). As a triterpenoid, it is lipophilic in nature, contributing to its classification within the broader terpenoid/steroid structural family. Typical concentration in Centella asiatica dry herb ranges from 0.1% to 0.9% by weight, depending on extraction method and plant part used. Asiatic acid is one of four major bioactive triterpenoids in Centella asiatica, alongside asiaticoside, madecassoside, and madecassic acid. Oral bioavailability is moderate and limited by poor water solubility (log P approximately 4.5–5.0), though nanoparticle formulations and lipid-based delivery systems have been shown to enhance absorption significantly. Peak plasma concentration (Tmax) occurs approximately 1–2 hours post-oral administration in animal models. It undergoes hepatic first-pass metabolism and is partially conjugated with glucuronic acid. No caloric value, protein, fiber, or micronutrient content is associated with this compound as a standalone isolate.

Preparation & Dosage

The research does not provide clinically studied dosage ranges for asiatic acid in humans. Without access to human clinical trial data, standardized dosing recommendations cannot be established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Resveratrol, Quercetin, Green Tea Extract, Lycopene

Safety & Interactions

Asiatic acid is generally considered well-tolerated in animal studies at moderate doses, but human safety data from controlled trials is limited. Because it inhibits CYP3A4 enzyme activity in vitro, it may potentiate the effects of drugs metabolized by this pathway, including certain statins, immunosuppressants, and chemotherapeutic agents. Its pro-apoptotic and ROS-generating activity theoretically warrants caution when combined with antioxidant supplements or antiapoptotic medications, as these may counteract its mechanism. Pregnant or breastfeeding individuals should avoid supplementation due to the absence of reproductive safety data.